SynthesisTherapeutic advances in respiratory disease

Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.

De-Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.